Kun Xie

1.0k total citations
37 papers, 771 citations indexed

About

Kun Xie is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Kun Xie has authored 37 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Kun Xie's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Immunotherapy and Immune Responses (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Kun Xie is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Immunotherapy and Immune Responses (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Kun Xie collaborates with scholars based in China, United States and Germany. Kun Xie's co-authors include Jianmin Fang, Tengfei Liu, Shuyue Wang, Kaiming Chen, Longzhen Zhang, Hua Gu, Hermann Brenner, Lena Koch‐Gallenkamp, Volker Arndt and Dong Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Kun Xie

37 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Xie China 16 317 242 146 100 94 37 771
Anne Bessard France 15 345 1.1× 257 1.1× 208 1.4× 64 0.6× 110 1.2× 28 909
Jianchao Zhang China 16 407 1.3× 282 1.2× 133 0.9× 171 1.7× 72 0.8× 48 983
Maria Trovato Italy 15 285 0.9× 215 0.9× 137 0.9× 101 1.0× 76 0.8× 42 764
Yinying Dong China 17 524 1.7× 334 1.4× 164 1.1× 347 3.5× 85 0.9× 30 1.2k
Jianghong Yu China 10 263 0.8× 102 0.4× 320 2.2× 108 1.1× 40 0.4× 25 740
Kosuke Yamaguchi Japan 14 346 1.1× 365 1.5× 148 1.0× 56 0.6× 33 0.4× 50 879
Weronika Kurowska Poland 16 388 1.2× 178 0.7× 328 2.2× 109 1.1× 56 0.6× 27 1.0k
Ian B. Nicoud United States 17 204 0.6× 90 0.4× 95 0.7× 45 0.5× 178 1.9× 33 628
Rebecca Conway United States 11 258 0.8× 202 0.8× 54 0.4× 141 1.4× 58 0.6× 20 893
Lijing Zhu China 16 206 0.6× 161 0.7× 143 1.0× 56 0.6× 71 0.8× 49 816

Countries citing papers authored by Kun Xie

Since Specialization
Citations

This map shows the geographic impact of Kun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Xie more than expected).

Fields of papers citing papers by Kun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Xie. The network helps show where Kun Xie may publish in the future.

Co-authorship network of co-authors of Kun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Xie. A scholar is included among the top collaborators of Kun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Xie. Kun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Luyao, Shifeng Lou, Dong Fu, et al.. (2025). Neuro-immune interactions: Exploring the anti-inflammatory role of the vagus nerve. International Immunopharmacology. 159. 114941–114941. 3 indexed citations
2.
Xu, Lijun, Bingyu Li, Zhaohua Zhu, et al.. (2022). Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 10(12). e005447–e005447. 11 indexed citations
3.
Tian, Pu, Jiangming Chen, Yijun Zhao, et al.. (2022). Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study. World Journal of Gastroenterology. 28(37). 5469–5482. 4 indexed citations
4.
Tian, Pu, et al.. (2021). Nomogram based on inflammation-related markers for predicting survival of patients undergoing hepatectomy for hepatocellular carcinoma. World Journal of Clinical Cases. 9(36). 11193–11207. 3 indexed citations
5.
Huang, Lei, Ruiqin Wang, Kun Xie, et al.. (2021). A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation. Breast Cancer Research and Treatment. 191(1). 51–61. 38 indexed citations
6.
Wang, Shuyue, Kun Xie, & Tengfei Liu. (2021). Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters. Frontiers in Immunology. 12. 690112–690112. 71 indexed citations
7.
Huang, Lei, Kun Xie, Hongwen Li, et al.. (2020). <p>Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody</p>. Drug Design Development and Therapy. Volume 14. 3201–3214. 10 indexed citations
8.
Chen, Zixiang, Xu Wang, Yi Zhou, et al.. (2020). Two novel online nomograms for predicting the survival of individual patients undergoing partial hepatectomy for huge hepatocellular carcinoma. HPB. 23(8). 1217–1229. 1 indexed citations
9.
Yin, Yanxin, Jia Guo, Fei Teng, et al.. (2019). <p>Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma</p>. Drug Design Development and Therapy. Volume 13. 4173–4184. 4 indexed citations
10.
Xie, Kun, et al.. (2018). Quality of life and physical activity in long-term (≥5 years post-diagnosis) colorectal cancer survivors - systematic review. Health and Quality of Life Outcomes. 16(1). 112–112. 77 indexed citations
11.
Zhu, Xingyang, et al.. (2017). Osthole induces apoptosis and suppresses proliferation via the PI3K/Akt pathway in intrahepatic cholangiocarcinoma. International Journal of Molecular Medicine. 40(4). 1143–1151. 32 indexed citations
12.
Li, Bingyu, Lijun Xu, Kun Xie, et al.. (2017). Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activityin vivo. Oncotarget. 8(24). 39356–39366. 19 indexed citations
13.
Zhu, Wei, Kun Xie, Le Wang, et al.. (2016). CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse. Virus Research. 217. 125–132. 57 indexed citations
14.
Xu, Lijun, Bingyu Li, Mengwen Huang, et al.. (2016). Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. PLoS ONE. 11(7). e0159426–e0159426. 14 indexed citations
15.
Song, Yanfeng, et al.. (2016). Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy. Oncotarget. 7(8). 8956–8967. 13 indexed citations
16.
17.
Ma, Qian, Yan Zhang, Ran Meng, et al.. (2015). MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.. PubMed. 28(7). 502–9. 16 indexed citations
18.
Wu, You, Ping Chen, Chen Wang, et al.. (2015). Microarray Analysis Reveals Potential Biological Functions of Histone H2B Monoubiquitination. PLoS ONE. 10(7). e0133444–e0133444. 9 indexed citations
19.
Wei, Xiaoyan, et al.. (2014). A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth. British Journal of Cancer. 111(1). 68–77. 22 indexed citations
20.
Chen, Ke, et al.. (2012). Splenomegaly as the first manifestation of pancreatic adenosquamous carcinoma: A case report. The Turkish Journal of Gastroenterology. 23(6). 799–803. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Bessard Breakdown of academic impact, for papers by Jianchao Zhang Breakdown of academic impact, for papers by Maria Trovato Breakdown of academic impact, for papers by Yinying Dong Breakdown of academic impact, for papers by Jianghong Yu Breakdown of academic impact, for papers by Kosuke Yamaguchi Breakdown of academic impact, for papers by Weronika Kurowska Breakdown of academic impact, for papers by Ian B. Nicoud Breakdown of academic impact, for papers by Rebecca Conway Breakdown of academic impact, for papers by Lijing Zhu
Rankless by CCL
2026